Use of mammography and Papanicolaou's test for the early detection of breast and uterine cervix cancer in Spain. IPE-02/34 (Public report)

Luengo S, Munoz A
Record ID 32003000480
Authors' objectives:

The prevention of gynaecologic cancer, especially breast and uterine cervix cancer, is a top priority in women's health, since death due to these processes can be, to a large extent, avoided. The objective of this study is to analyse the current situation of early detection programmes for breast and uterine neck cancer in Spain, as well as learn about the use of mammography and Papanicolaou's test in Spanish women aged 40-70.

Authors' recommendations: All Autonomous Communities (AC) have well established population screening programmes for early detection of breast cancer, which include carrying out a mammography, and some have already covered all the women in the target population. The early detection programmes for cervix cancer are established to a larger or lesser extent in certain AC and perform Papanicolaous test. Most are opportunistic screening and usually include primary care equipment for their development. More than half of Spanish women aged 40 to 70 had had at least one mammography in the last two years, and in most cases they had done it for preventive reasons. Women aged 51 to 60 are the women who, with more frequency, had received the mammogram. Likewise, just over half the women had had a Papanicolaou cytology in the last three years, and in most cases it was also for preventive reasons. More young women then older women have the cytology done. We believe it would be interesting to learn about the factors related to the use of mammography and Papanicolaous test in Spain.
Authors' methods: Survey, Review
Project Status: Completed
URL for project:
Year Published: 2001
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Spain
MeSH Terms
  • Breast Neoplasms
  • Mammography
  • Mass Screening
  • Uterine Cervical Neoplasms
  • Vaginal Smears
Organisation Name: Agencia de Evaluacion de Tecnologias Sanitarias
Contact Address: Jose Luis de Sancho Martin, Instituto de Salud "Carlos III", Calle Sinesio Delgado 6, Pabellon 4, 28029 Madrid, Spain. Tel: +34 9 1 822 2005; Fax: +34 9 1 387 7841;
Contact Name:
Contact Email:
Copyright: Agencia de Evaluacion de Tecnologias Sanitarias (AETS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.